Dolat Capital's research report on Dilip Buildcon
We drastically reduce our revenue estimates by 24.8%/ 17.9% for FY21E/ FY22E on account of loss of revenue led by lockdown due to covid-19. We decrease EBITDA margin estimates for FY21E/ FY22E by 50/ 20 bps to 16.0%/ 16.5%. Accordingly, we lower our APAT estimates by 72.2%/ 41.9% for FY21E/ FY22E. The sharp reduction in APAT is due to sizable depreciation (average Rs4.5 bn) and finance cost (average Rs5.7 bn) despite factoring Rs4 bn/ Rs506 mn debt reduction in FY21E/ FY22E. We expect DBL’s revenue/ Adj. APT to de-grow at CAGR of 2.1%/ 16.5% over FY20-22E. The management has refrained from giving any guidance until any clarity emerges. Though the stock has corrected/ increased ~34%/ 17% since our Q3FY20/ Covid report on 10th Feb’20/ 24th Mar’20, we believe the fixed cost model (owning equipment + relatively higher debt) of DBL will be severely impacted due to loss of revenue.
Outlook
We reduce to Accumulate with a downward revised SOTP of Rs275 (7x FY22E EPS + 1x FY22E PB for equity investment in HAM).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!